Beta-d-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding

Biochemical Pharmacology

Volumn 84, Issue 12, 2012, Pages 1681-1690

  Mahali, Sidhartha K ^a   Manna, Sunil K ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

AGE; Diabetes; ERK; Mangiferin; NF B; PPAR gamma

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANANDAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN; MITOGEN ACTIVATED PROTEIN KINASE; OLEAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TROGLITAZONE;

ARTICLE; CELL NUCLEUS; COMPUTER MODEL; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; DNA BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; PRIORITY JOURNAL;

BASE SEQUENCE; DIABETES COMPLICATIONS; DNA; DNA PRIMERS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84869217946     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.09.033     Document Type: Article

References (34)

1. C. Franceschi, M. Bonafe, S. Valensin, F. Olivieri, M. De Luca, and E. Ottaviani Inflam-aging an evolutionary perspective on immunoscenescence Ann NY Acad Sci 908 2000 244 254
2. S. Yamagishi, K. Nakamura, and T. Matsui Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy Curr Drug Discov Technol 3 2006 83 88
3. H. Odani, T. Shinzato, Y. Matsumoto, J. Usami, and K. Maeda Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction Biochem Biophys Res Commun 256 1999 89 93
4. A. Lapolla, R. Flamini, A.D. Vedova, A. Senesi, R. Reitano, and D. Fedele Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method Clin Chem Lab Med 41 2003 1166 1173
5. M.Y. Khuhawar, A.J. Kandhro, and F.D. Khand Liquid chromatographic determination of glyoxal and methylglyoxal from serum of diabetic patients using meso-stilbenediamine as derivatizing reagents Anal Lett 39 2006 2205 2215
6. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end products: a review Diabetologia 44 2001 129 146
7. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, and J. Zhang Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1995 1395 1403
8. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1997 82 86
9. R. Walczakm, and Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism J Lipid Res 43 2002 177 186
10. Y. Li, Y. Qi, T.H. Huang, J. Yamahara, and B.D. Roufogalis Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties Diabetes Obes Metab 10 2008 10 17
11. E. Burgermeister, D. Chuderland, T. Hanoch, M. Meyer, M. Liscovitch, and R. Seger Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma Mol Cell Biol 27 2006 803 817
12. N. Cho, and Y. Momose Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress Curr Top Med Chem 8 2008 1483 1507
13. S. Burstein PPAR-gamma: a nuclear receptor with affinity for cannabinoids Life Sci 77 2005 1674 1684
14. A. Sarkar, Y. Sreenivasan, G.T. Ramesh, and S.K. Manna Beta-d-glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis J Biol Chem 279 2004 33768 33781
15. S. Muruganandan, K. Srinivasan, S. Gupta, P.K. Gupta, and J. Lal Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats J Ethnopharmacol 97 2005 497 501
16. 2+ mediated by interleukin-8 protein J Biol Chem 286 2011 34903 34913
17. S.K. Manna, J.S. Bose, V. Gangan, N. Raviprakash, T. Navneetha, and P.B. Raghavendra Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB J Biol Chem 285 2010 22318 22327
18. S.K. Manna, P. Manna, and A. Sarkar Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells Cell Death Differ 14 2007 158 170
19. C. Gangadharan, M. Thoh, and S.K. Manna Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL Breast Cancer Res Treat 120 2010 671 683
20. S.K. Manna, B. Babajan, P.B. Raghavendra, N. Raviprakash, and Kumar C.S. Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1 J Biol Chem 285 2010 11617 11627
21. A.W. Schuettelkopf, and D.M. van Aalten PRODRG: a tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr 60 2004 1355 1363
22. M.F. Sanner Python: a programming language for software integration and development J Mol Graph Model 17 1999 57 60
23. R. Huey, G.M. Morris, A.J. Olson, and D.S. Goodsell A semiempirical free energy force field with charge-based desolvation J Comb Chem 28 2007 145 152
24. W.C. Stallings, S.S. Abdel-Meguid, L.W. Lim, H.S. Shieh, H.E. Dayringer, and N.K. Leimgruber Structure and topological symmetry of the glyphosate target 5-enol-pyruvylshikimate-3-phosphate synthase: a distinctive protein fold Proc Natl Acad Sci USA 88 1991 5046 5050
25. J. DiStefano, and R.M. Watanabe Pharmacogenetics of anti-diabetes drugs Pharmaceuticals 3 2010 2610 2646
26. A. Antonelli, S.M. Ferrari, P. Fallahi, P. Berti, G. Materazzi, and I. Marchetti Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration Eur J Endocrinol 159 2008 283 291
27. A. Hiukka, M. Maranghi, N. Matikainen, and M.R. Taskinen PPARα: an emerging therapeutic target in diabetic microvascular damage Nat Rev Endocrinol 6 2010 454 463
28. M.A. Jay, and J. Ren Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus Curr Diabetes Rev 3 2007 33 39
29. Q. Yang, C. Chen, S. Wu, Y. Zhang, X. Mao, and W. Wang Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway Eur J Pharmacol 649 2010 108 114
30. A.S. Wilkinson, G.R. Monteith, N. Shaw, C.N. Lin, M.J. Gidley, and S.J. Roberts-Thomson Effects of mango components mangiferin and quercetin and the putative mangiferin metabolite norathyrion on the transctivation of peroxisome proliferator activator receptor isoforms J Agric Food Chem 56 2008 3037 3042
31. M.D. Giron, N. Sevillano, R. Salto, A. Haidour, M. Manzano, and M.L. Jimenez Salacia oblonga extracts increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin Clin Nutr 28 2009 565 574
32. Z. Gao, Q. He, B. Peng, P.J. Chiao, and J. Ye Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function J Biol Chem 281 2006 4540 4547
33. M.F. Favata, K.Y. Horiuchi, E.J. Manos, A.J. Daulerio, D.A. Stradley, and W.S. Feeser Identification of a novel inhibitor of mitogen-activated protein kinase kinase J Biol Chem 273 1998 18623 18632
34. T.C. Grammer, and J. Blenis Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases Oncogene 14 1997 1635 1642